Business Description
Theranexus SA
ISIN : FR0013286259
Compare
Compare
Traded in other countries / regions
ALTHX.France3VG.Germany IPO Date
2017-10-30Description
Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.6 | |||||
| Debt-to-Equity | -978.67 | |||||
| Debt-to-EBITDA | -0.78 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 10.7 | |||||
| 3-Year EPS without NRI Growth Rate | 10.3 | |||||
| 3-Year FCF Growth Rate | 17.6 | |||||
| 3-Year Book Growth Rate | -51.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.6 | |||||
| 9-Day RSI | 62.5 | |||||
| 14-Day RSI | 61.33 | |||||
| 6-1 Month Momentum % | -39.32 | |||||
| 12-1 Month Momentum % | -55.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.45 | |||||
| Quick Ratio | 2.45 | |||||
| Cash Ratio | 1.41 | |||||
| Days Payable | 101.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.4 | |||||
| Shareholder Yield % | 23.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -190.34 | |||||
| ROA % | -47.46 | |||||
| ROIC % | -204.55 | |||||
| ROC (Joel Greenblatt) % | -1539.63 | |||||
| ROCE % | -74.01 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.1 | |||||
| EV-to-EBIT | -1.47 | |||||
| EV-to-EBITDA | -1.53 | |||||
| EV-to-FCF | -1.2 | |||||
| Earnings Yield (Greenblatt) % | -68.31 | |||||
| FCF Yield % | -104.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Theranexus SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.394 | ||
| Beta | 1.26 | ||
| Volatility % | 92.63 | ||
| 14-Day RSI | 61.33 | ||
| 14-Day ATR (€) | 0.034362 | ||
| 20-Day SMA (€) | 0.52355 | ||
| 12-1 Month Momentum % | -55.36 | ||
| 52-Week Range (€) | 0.46 - 1.348 | ||
| Shares Outstanding (Mil) | 7.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Theranexus SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Theranexus SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Theranexus SA Frequently Asked Questions
What is Theranexus SA(XPAR:ALTHX)'s stock price today?
The current price of XPAR:ALTHX is €0.58. The 52 week high of XPAR:ALTHX is €1.35 and 52 week low is €0.46.
When is next earnings date of Theranexus SA(XPAR:ALTHX)?
The next earnings date of Theranexus SA(XPAR:ALTHX) is .
Does Theranexus SA(XPAR:ALTHX) pay dividends? If so, how much?
Theranexus SA(XPAR:ALTHX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers